RIFAXIMIN



Semi-synthetic antibiotic derived from Rifamycin

Specification – pharmacopeia: EP, BP, In House

Therapeutic category: antibiotic (travelers’ diarrhea)

Treatment: for traveler's diarrhea, produced by non-invasive strains of Escherichia coli.



Pharmacology: prevents the synthesis of DNA from the bacterium by binding to the RNA polymerase; thus it is not absorbed in the digestive tract, is used as an intestinal antibiotic.

Application: human & veterinary

CAS number: 80621-81-4

Chemical formula: C43H51N3O11

sales@interquim.com.mx